Molecular Profiling of Inflammatory Processes in a Mouse Model of IC/BPS: From the Complete Transcriptome to Major Sex-Related Histological Features of the Urinary Bladder
article
OA: gold
CC0
Abstract
Animal models are invaluable in the research of the pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic aseptic urinary bladder disease of unknown etiology that primarily affects women. Here, a mouse model of IC/BPS was induced with multiple low-dose cyclophosphamide (CYP) applications and thoroughly characterized by RNA sequencing, qPCR, Western blot, and immunolabeling to elucidate key inflammatory processes and sex-dependent differences in the bladder inflammatory response. CYP treatment resulted in the upregulation of inflammatory transcripts such as Ccl8, Eda2r, and Vegfd, which are predominantly involved in innate immunity pathways, recapitulating the crucial findings in the bladder transcriptome of IC/BPS patients. The JAK/STAT signaling pathway was analyzed in detail, and the JAK3/STAT3 interaction was found to be most activated in cells of the bladder urothelium and lamina propria. Sex-based data analysis revealed that cell proliferation was more pronounced in male bladders, while innate immunity and tissue remodeling processes were the most distinctive responses of female bladders to CYP treatment. These processes were also reflected in prominent histological changes in the bladder. The study provides an invaluable reference dataset for preclinical research on IC/BPS and an insight into the sex-specific mechanisms involved in the development of IC/BPS pathology, which may explain the more frequent occurrence of this disease in women.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (72)
- W7988435 via openalex
- W1617495083 via openalex
- W1964241768 via openalex
- W1981895433 via openalex
- W1988943632 via openalex
- W2005508596 via openalex
- W2015638728 via openalex
- W2022363810 via openalex
- W2026634713 via openalex
- W2027735589 via openalex
- W2037449100 via openalex
- W2045246370 via openalex
- W2052649926 via openalex
- W2054517864 via openalex
- W2073924006 via openalex
- W2092238235 via openalex
- W2092334369 via openalex
- W2099540110 via openalex
- W2099745827 via openalex
- W2108400693 via openalex
- W2111351802 via openalex
- W2118183372 via openalex
- W2128049766 via openalex
- W2144466949 via openalex
- W2155095558 via openalex
- W2157002123 via openalex
- W2158363989 via openalex
- W2168704375 via openalex
- W2253818064 via openalex
- W2301044272 via openalex
- W2581448715 via openalex
- W2599566629 via openalex
- W2599889833 via openalex
- W2606391767 via openalex
- W2718751133 via openalex
- W2756945639 via openalex
- W2760973261 via openalex
- W2766965802 via openalex
- W2787723196 via openalex
- W2788447215 via openalex
- W2906574570 via openalex
- W2921956301 via openalex
- W2929073081 via openalex
- W2947537190 via openalex
- W2970372573 via openalex
- W2972819506 via openalex
- W2973429485 via openalex
- W3001733563 via openalex
- W3015738731 via openalex
- W3040924555 via openalex
- W3082053594 via openalex
- W3119624913 via openalex
- W3127486072 via openalex
- W3130839889 via openalex
- W3158038444 via openalex
- W3168425438 via openalex
- W3184637338 via openalex
- W3187014282 via openalex
- W3205480177 via openalex
- W3216146155 via openalex
- W4200012134 via openalex
- W4200512957 via openalex
- W4205188344 via openalex
- W4212987214 via openalex
- W4224685066 via openalex
- W4229440144 via openalex
- W4286716906 via openalex
- W4291018780 via openalex
- W4291465259 via openalex
- W4292878185 via openalex
- W4308834893 via openalex
- W4309977053 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK